Advances in Cell and Gene Therapy for Rare Disease Treatment
Open Access
- 1 September 2025
- journal article
- review article
- Published by Korean Society for Stem Cell Research in International Journal of Stem Cells
- Vol. 18 (4) , 324-337
Abstract
Hyun Jin Baek, Yoojun Nam, Yeri Alice Rim, Ji Hyeon Ju. IJSC -0001;0:. https://doi.org/10.15283/ijsc25028Keywords
Funding Information
- Korea Health Industry Development Institute (HI22C1314)
- Ministry of Health and Welfare (HI22C1314)
- Ministry of SMEs and Startups (RS-2023-00304053)
This publication has 59 references indexed in Scilit:
- Progress in Rare Diseases Research 2010–2016: An IRDiRC PerspectiveClinical and Translational Science, 2017
- Future of Rare Diseases Research 2017–2027: An IRDiRC PerspectiveClinical and Translational Science, 2017
- Drug discovery and development for rare genetic disordersAmerican Journal of Medical Genetics Part A, 2017
- Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease TrialsValue in Health, 2017
- Overcoming Challenges Facing Advanced Therapies in the EU MarketCell Stem Cell, 2016
- Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 CountriesPLOS ONE, 2015
- The portal for rare diseases and orphan drugsJournal of Pharmacology and Pharmacotherapeutics, 2013
- Orphan Drugs for Rare DiseasesDrugs, 2012
- RNAi and small interfering RNAs in human disease therapeutic applicationsTrends in Biotechnology, 2010
- Translation of rare disease research into orphan drug development: disease mattersDrug Discovery Today, 2009